An-Con Genetics reports improved revenues and net income for third quarter and nine month periods.MELVILLE, N.Y.--(BUSINESS WIRE)--Nov. 17, 1995--An-Con Genetics Inc. (OTC Bulletin Board OTC Bulletin Board An electronic quotation listing of the bid and asked prices of OTC stocks that do not meet the requirements to be listed on the NASDAQ stock-listing system. : AGNT AGNT Association for Global New Thought AGNT Agent Table ), today announced that revenues for the third quarter of fiscal year 1995 ended Sept. 30, 1995, reached a record $1,516,300 representing a 36.2 percent increase over $1,113,000 recorded on a pro forma As a matter of form or for the sake of form. Used to describe accounting, financial, and other statements or conclusions based upon assumed or anticipated facts. The phrase pro forma basis in the comparable period last year. Net income improved to $52,300 versus a pro forma net loss of ($466,500) in the same period of fiscal 1994. For the first nine months of the current fiscal year, sales increased 28.9 percent reaching $4,108,600, resulting in a net income of $11,500, less than one cent per share. For the comparable period in the prior year the company experienced a pro forma net loss of ($609,700) or a 20 cent per share loss on pro forma revenues of $3,186,300. Management commented that the positive financial results combined with the launching of the company's new proprietary tissue fixative fixative /fix·a·tive/ (fik´sit-iv) an agent used in preserving a histological or pathological specimen so as to maintain the normal structure of its constituent elements. fix·a·tive adj. OmniFix 2000, a safe alternative to formalin formalin /for·ma·lin/ (for´mah-lin) formaldehyde solution. for·ma·lin n. An aqueous solution of formaldehyde that is 37 percent by weight. (formaldehyde), enhances An-Con's growth potential. Chairman J. Robert Saron, added, "We are extremely pleased with the positive response to our Resistick reduced stick blades, introduced at the American College of Surgeons This article or section needs sources or references that appear in reliable, third-party publications. Alone, primary sources and sources affiliated with the subject of this article are not sufficient for an accurate encyclopedia article. annual meeting in New Orleans, in October 1995. The blades offer superior cutting and coagulation coagulation (kōăg'y  lā`shən), the collecting into a mass of minute particles of a solid dispersed throughout a liquid (a sol), usually followed by the precipitation or when compared to current reduced stick electrodes on the market." In other news An-Con Genetics Inc. has appointed two new members of its board, bringing the total number of directors to four: Joseph F. Valenti, former vice president of the International Division of Aaron Medical Industries Inc. and George W. Kromer Jr., a senior financial correspondent for a national business publication. An-Con Genetics, through its wholly-owned subsidiary Aaron Medical Industries, is engaged in the manufacturing and marketing of a diverse line of premium medical devices and proprietary tissue fixatives. CONTACT: An-Con Genetics Inc., Melville Andrew Makrides, 516/694-8470 |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion